$5.14
0.163.21%
At close: -
$5.14
0.000.00%
After Hours: Dec 20, 4:00 PM EDT
Foghorn Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Foghorn Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $-0.31 | $-0.44 | 29.5 % |
Jun 2024 | 2024-08-08 | $-0.45 | $-0.65 | 30.8 % |
Mar 2024 | 2024-05-06 | $-0.59 | $-0.63 | 6.35 % |
Dec 2023 | 2024-03-07 | $-0.57 | $-0.76 | 25.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $7.81M | $6.34M | 23.2 % |
Jun 2024 | 2024-08-08 | $6.89M | $6.04M | 14.0 % |
Mar 2024 | 2024-05-06 | $5.05M | $6.91M | -26.9 % |
Dec 2023 | 2024-03-07 | $5.77M | $4.62M | 24.9 % |
Foghorn Therapeutics (FHTX) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $-0.31, which beat the estimate of $-0.44.
The Actual Revenue was $7.8M, which beat the estimate of $6.3M.
Browse earnings estimates, EPS, and revenue on all stocks.